Philip has made over 1 trades of the Amyris Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently he bought 28,000 units of AMRS stock worth $700,000 on 21 July 2016.
The largest trade he's ever made was buying 28,000 units of Amyris Inc stock on 21 July 2016 worth over $700,000. On average, Philip trades about 2,800 units every 0 days since 2016. As of 21 July 2016 he still owns at least 28,000 units of Amyris Inc stock.
You can see the complete history of Mr. Eykerman stock trades at the bottom of the page.
Philip Eykerman serves as Director of the Company. Mr. Eykerman has served as the Executive Vice-President, Corporate Strategy & Acquisitions of Koninklijke DSM N.V. (together with its affiliates, “DSM”), a global science-based company in nutrition, health and sustainable living and an entity with which Amyris has a commercial and financial relationship and which is an owner of greater than five percent of the Company’s outstanding common stock, since 2011. In this role, he is responsible for corporate and business group strategy development, budgeting and planning, improvement programs, and all M&A activities for DSM. In 2015, he was also appointed as a member of the DSM Executive Committee and at present is also responsible for the DSM Food Specialties as well as DSM Hydrocolloids activities. Next to these roles within DSM, he is also a Supervisory Board member of ChemicaInvest (DSM/CVC JV), AnQore TopCo B.V., and AOC Aliancys (DSM/CVC JV), and previously served as a member of the Supervisory Board of Patheon N.V. from March 2014 to August 2017. Before joining DSM, Mr. Eykerman worked for 14 years at McKinsey & Company of which the last 9 years as a Partner and leader of McKinsey’s Chemicals Practice in the Benelux and France. Before that, he worked as a process/ project engineer for Fluor Daniel. He holds a Master’s degree in Chemical Engineering from the KU Leuven (Belgium), and a Master’s degree in Refinery Engineering from the Institut Francais du Pétrole (France).
As the Director of Amyris Inc, the total compensation of Philip Eykerman at Amyris Inc is $58,126. There are 13 executives at Amyris Inc getting paid more, with John G. Melo having the highest compensation of $1,344,913.
Philip Eykerman is 52, he's been the Director of Amyris Inc since 2017. There are 18 older and 2 younger executives at Amyris Inc. The oldest executive at Amyris Inc is Patrick Yang, 72, who is the Independent Director.
Philip's mailing address filed with the SEC is C/O AMYRIS, INC., 5885 HOLLIS STREET, SUITE 100, EMERYVILLE, CA, 94608.
Over the last 14 years, insiders at Amyris Inc have traded over $118,642,007 worth of Amyris Inc stock and bought 100,049,915 units worth $258,812,433 . The most active insiders traders include Gas & Power Usa, Sas Total, L John Doerr, and Philippe Boisseau. On average, Amyris Inc executives and independent directors trade stock every 25 days with the average trade being worth of $65,903. The most recent stock trade was executed by Hermanus Kieftenbeld on 2 June 2023, trading 20,999 units of AMRS stock currently worth $19,949.
amyris is the integrated renewable products company that is enabling the world’s leading brands to achieve sustainable growth. amyris applies its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules, specialty ingredients and consumer products. the company is delivering its no compromise® products in focused markets, including specialty and performance chemicals, fragrance ingredients, and cosmetic emollients. more information about the company is available at www.amyris.com.
Amyris Inc executives and other stock owners filed with the SEC include: